NCT06651242 Decision Support Intervention of Minor Cancer Patients and Their Parents
| NCT ID | NCT06651242 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kaohsiung Medical University Chung-Ho Memorial Hospital |
| Condition | Pediatric Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2022-10-26 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2022-10-26 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this stuidy are: (1) to explore the information needs of parents having children with cancer when making treatment decisions; (2) to develop a Taiwan version of the Control Preferences Scale for decision support aids; (3) to implement and evaluate the effectiveness of involving minor cancer patients and their parents in treatment decision-making.
Eligibility Criteria
Inclusion Criteria: * Inclusion Criteria for Parents: 1. Age over 20 years. 2. Child under 20 years old, diagnosed with cancer by a doctor. 3. their child know her/his cancer diagnosis. 4. Agree to have the child participate in family meeting and have ability to communicate in Mandarin or Taiwanese. * Inclusion Criteria for Minors: 1. Aged between 7 and 20 years, diagnosed with pediatrtic cancer. 2. Aware of their cancer diagnosis. 3. Able to express their thoughts to the researcher in Mandarin or Taiwanese. 4. Both the minor and their legal guardian consent to participate in the study. Exclusion Criteria: 1. Diagnosed with depression, and/or anxiety, and/or other mental disorders. 2. Legal guardian is unwilling to inform the minor of their diagnosis. 3. Minor is unwilling to share their thoughts with their parents.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06651242 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 20 Years, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06651242 currently recruiting?
Yes, NCT06651242 is actively recruiting participants. Contact the research team at painting@kmu.edu.tw for enrollment information.
Where is the NCT06651242 trial being conducted?
This trial is being conducted at Kaohsiung City, Taiwan.
Who is sponsoring the NCT06651242 clinical trial?
NCT06651242 is sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.